- Home
- BPMC vs NOVT Comparison
BPMC vs NOVT Comparison
Compare BPMC & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BPMC
- NOVT
- Stock Information
- Founded
- BPMC 2008
- NOVT 1968
- Country
- BPMC United States
- NOVT United States
- Employees
- BPMC N/A
- NOVT N/A
- Industry
- BPMC Biotechnology: Pharmaceutical Preparations
- NOVT Industrial Machinery/Components
- Sector
- BPMC Health Care
- NOVT Miscellaneous
- Exchange
- BPMC Nasdaq
- NOVT Nasdaq
- Market Cap
- BPMC 5.8B
- NOVT 5.1B
- IPO Year
- BPMC 2015
- NOVT N/A
- Fundamental
- Price
- BPMC $90.01
- NOVT $128.09
- Analyst Decision
- BPMC Buy
- NOVT Hold
- Analyst Count
- BPMC 22
- NOVT 1
- Target Price
- BPMC $124.29
- NOVT $160.00
- AVG Volume (30 Days)
- BPMC 950.3K
- NOVT 220.0K
- Earning Date
- BPMC 05-01-2025
- NOVT 05-06-2025
- Dividend Yield
- BPMC N/A
- NOVT N/A
- EPS Growth
- BPMC N/A
- NOVT N/A
- EPS
- BPMC N/A
- NOVT 1.77
- Revenue
- BPMC $508,824,000.00
- NOVT $949,245,000.00
- Revenue This Year
- BPMC $45.43
- NOVT $7.24
- Revenue Next Year
- BPMC $32.80
- NOVT $7.07
- P/E Ratio
- BPMC N/A
- NOVT $72.03
- Revenue Growth
- BPMC 104.04
- NOVT 7.67
- 52 Week Low
- BPMC $80.68
- NOVT $125.42
- 52 Week High
- BPMC $121.90
- NOVT $187.12
- Technical
- Relative Strength Index (RSI)
- BPMC 47.63
- NOVT 30.15
- Support Level
- BPMC $84.55
- NOVT $125.42
- Resistance Level
- BPMC $93.04
- NOVT $137.81
- Average True Range (ATR)
- BPMC 3.55
- NOVT 3.31
- MACD
- BPMC 0.19
- NOVT -0.65
- Stochastic Oscillator
- BPMC 47.60
- NOVT 11.95
Stock Price Comparison Chart: BPMC vs NOVT
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.
About NOVT Novanta Inc.
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.